Literature DB >> 17083336

Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis.

L Lovrecić1, S Ristić, N Starcević-Cizmarević, S S Jazbec, J Sepcić, M Kapović, B Peterlin.   

Abstract

OBJECTIVES: Angiotensin-converting enzyme (ACE) activity is increased in blood and cerebrospinal fluid of patients with multiple sclerosis (MS). In addition, in experimental autoimmune encephalomyelitis (EAE), an animal model of MS, the blockade of ACE suppresses the disease itself. To analyze the genetic association of the ACE gene with MS, we examined ACE gene insertion/deletion (I/D) polymorphism in MS patients.
MATERIALS AND METHODS: A total of 313 MS patients from Slovenia and Croatia and 376 healthy controls were genotyped by polymerase chain reaction method.
RESULTS: We found statistically significant differences in the distribution of ACE I/D allele frequencies (P < 0.01) and genotypes (P < 0.04) in male patients. ACE DD genotype was associated with MS in men at an odds ratio of 1.86 (95% CI 1.09-3.19, P = 0.02).
CONCLUSIONS: DD genotype of ACE gene might contribute to a higher risk of developing MS in men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17083336     DOI: 10.1111/j.1600-0404.2006.00711.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

1.  Angiotensin-converting enzyme insertion/deletion gene polymorphism in multiple sclerosis: a meta-analysis.

Authors:  Smiljana Ristić; Nada Starčević Čizmarević; Juraj Sepčić; Miljenko Kapović; Borut Peterlin
Journal:  Neurol Sci       Date:  2016-08-27       Impact factor: 3.307

2.  Modulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis.

Authors:  A Uzawa; M Mori; J Taniguchi; S Kuwabara
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

3.  Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.

Authors:  Michael Platten; Sawsan Youssef; Eun Mi Hur; Peggy P Ho; May H Han; Tobias V Lanz; Lori K Phillips; Matthew J Goldstein; Roopa Bhat; Cedric S Raine; Raymond A Sobel; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-19       Impact factor: 11.205

4.  The lack of association between angiotensin-converting enzyme gene insertion/deletion polymorphism and nicotine dependence in multiple sclerosis.

Authors:  Sergej Nadalin; Alena Buretić-Tomljanović; Polona Lavtar; Nada Starčević Čizmarević; Alenka Hodžić; Juraj Sepčić; Miljenko Kapović; Borut Peterlin; Smiljana Ristić
Journal:  Brain Behav       Date:  2016-11-14       Impact factor: 2.708

5.  Could angiotensin-converting enzyme 1 I/D polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?

Authors:  Sanja Dević Pavlić; Sergej Nadalin; Nada Starčević Čizmarević; Alena Buretić-Tomljanović; Anđelka Radojčić Badovinac; Smiljana Ristić
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Jul-Sep       Impact factor: 1.636

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.